Mobocertinib Medicare Coverage: What Patients with Lung Cancer Need to Know

The current price of Mobocertinib after medical insurance reimbursement in China is influenced by specific circumstances. If you choose the generic version produced in India, the price is relatively lower, and the specific cost may be affected by factors such as purchasing channels and exchange rates.

Price After Inclusion in Medical Insurance

Mobocertinib has been included in the National Reimbursement Drug List. After insurance reimbursement, the actual financial burden on patients is significantly reduced.

This price represents a substantial decrease compared to the original cost, alleviating the economic pressure on patients requiring long-term medication.

Price of the Indian Generic Version

In the Indian market, a generic version of Lucius Pharmaceuticals Mobocertinib (with the same brand name) is available.

The generic version is also packaged as 112 tablets per box, and its price is significantly lower than that of the version covered by medical insurance.

Important Notes

The above prices are current reference information (some data may be marked as 2025 and could be subject to fluctuations). For actual purchases, real-time quotes from local pharmacies or medical institutions should be consulted.

The specification is uniformly 40mg*112 tablets per box. Prices for different specifications or packaging will vary accordingly.

The purchase of Indian generic drugs involves cross-border pharmaceutical regulations. It is essential to choose legal and compliant channels carefully and to follow medical advice when using them.

Domestic medical insurance policies and reimbursement rates vary by region. The final out-of-pocket expenses should be calculated based on specific local conditions.